Timothy Walker

Tim is a contributing analyst for EconomicCalendar.com and specializes in equities trading and public offerings. He is a graduate of UCLA and began his career doing capital markets research for a top investment banking software provider.

Deutsche Bank Starts Covering TherapeuticsMD (TXMD) With A Buy

TherapeuticsMD Inc (NYSEMKT:TXMD) is making some impressive gains today, following the news that Deutsche Bank initiated coverage on the company’s stock – kicking things...
scientist lab pharmaceutical

Revenue Beat Drives Sarepta Therapeutics (SRPT) 25% Higher

Sarepta Therapeutics Inc (NASDAQ:SRPT) is soaring today, with its shares currently up $8.58 at $42.67 in early-afternoon trading – a 25 percent boost. The...
dna pharmaceuticals

Vertex Pharma (VRTX) Skyrockets Following CF Trial Data

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is making some incredible gains today, currently trading nearly $28.00 higher at $160.04 – a 21 percent boost. Trade volume...

Puma Biotech (PBYI) Scores Breast Cancer FDA Approval

Puma Biotechnology Inc (NASDAQ:PBYI) is trading considerably higher this morning, following the news that the company’s breast cancer therapy has been approved by the...
scientist lab pharmaceutical

BioLife Solutions (BLFS) Scores Regulatory Approval In Korea

BioLife Solutions Inc (NASDAQ:BLFS) is trading a bit higher today, following the company’s announcement that its osteoarthritis therapy has been granted marketing approval by...

CEO Of AstraZeneca (AZN) Rumored To Be Heading To Teva (TEVA)

AstraZeneca plc (NYSE:AZN) and Teva Pharmaceuticals Industries Ltd (NYSE:TEVA) are the center of a lot of buzz today, after rumors began swirling that the...

Nektar Therapeutics (NKTR) Spikes On T-Cell Drug Data

Nektar Therapeutics (NKTR) is making some impressive gains today, as the company’s stock is currently trading $1.38 higher at $20.89 – a seven percent...
dna pharmaceuticals

FDA Reversal Drives Amicus Therapeutics (FOLD) 25% Higher

Amicus Therapeutics Inc (NASDAQ:FOLD) is surging today, with its share price up $2.61 at $12.87 in early-afternoon trading – a 25 percent boost. Before...

Bioverativ (BIVV) Is Set To Soar

Bioverativ Inc (NASDAQ:BIVV) is gaining slightly today, with its share price currently $1.45 higher at $61.76 in early afternoon trading – a 2.4 percent...
scientist lab pharmaceutical

Arena Pharmaceuticals (ARNA) Spikes On JMP Upgrade

Arena Pharmaceuticals Inc (NASDAQ:ARNA) is trading about nine percent higher this afternoon, up $1.59 to $19.58 at the time of writing. Before the market...

Upcoming Economic Events

Other News

US Dollar

DJIA Today: Dow Jones Futures Pare Losses but GE Weighs

The Dow Jones Industrial Average settled off session lows Friday, as disappointing earnings for industrial bellwether General Electric (NYSE: GE) weighed.The blue-chip index dropped...

S&P 500 Futures Flat as Energy, Industrials Lag

U.S. stocks ended the week on a softer note, as shares of energy and industrial companies led the declines.The large-cap S&P 500 Index pared...
natural gas

Slide In Crude Oil Undermines Natural Gas Prices, Positioning In Focus

Natural gas was unable to make any further headway following Thursday’s storage data with an element of profit taking following gains during the week...
New Zealand

NZD/USD Breaks To 10-Month High, On Pace To Post Fifth Consecutive Daily Advance

NZD/USD has gained every day this week and is seen breaking above November highs today to break to a 10-month high. The pair...
crude oil pumpjack

Baker Hughes US Oil Rig Count Declines To 764, 2nd Decline Since Late June

The total Baker Hughes North American rig count for the week ending July 21st declined to 950 from 952 the previous week.The number of...